Michelle Malkin: Taxing medical progress to death

Published



Two years ago this month, as public debate over Obamacare raged, former President Bill Clinton rushed to the hospital because of a heart condition. He immediately underwent a procedure to place two stents in one of his coronary arteries.

It was a timely reminder about the dangers of stifling private-sector medical innovation. No one listened. Stents don’t grow on trees. They were not created, developed, marketed or sold by government bureaucrats and lawmakers.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.